Connectyx Technologies Holdings Group, Inc. announced the addition of I Richard Garr as chief executive officer and general counsel. Mr. Garr was former president & CEO and general counsel, Neuralstem Inc. (1997-2016), where he had responsibility and oversight worldwide for all operations of a leading regenerative medicine company including: IP portfolio prosecution; defense and management; worldwide regulatory affairs; worldwide licensing and business development and collaborations; capital raises; social media and public relations programs. Mr. Garr is also the founder and managing partner of Access Hope CRO, the first CRO dedicated exclusively to Right to Try treatment programs, at scale, to accelerate drug development. Mr. Garr's nonprofit affiliations and work include: a co-founding director of the Starlight Mid Atlantic Foundation; The First Star Foundation and the First Star Institute; a group of charities involved in helping seriously ill children and abused and neglected children; a director on the National Advisory Counsel for Right To Try; a group involved in expanding access to clinical trial stage treatments for dying patients; in addition to considerable work with, and for, various state chapters of the ALS Society of America, the National Brain Tumor Foundation and the Paralyzed Veterans of America.